The contribution of depressive 'disorder characteristics' to determinations of prognosis for adults with depression: an individual patient data meta-analysis
The contribution of depressive 'disorder characteristics' to determinations of prognosis for adults with depression: an individual patient data meta-analysis
BACKGROUND: This study aimed to investigate general factors associated with prognosis regardless of the type of treatment received, for adults with depression in primary care.
METHODS: We searched Medline, Embase, PsycINFO and Cochrane Central (inception to 12/01/2020) for RCTs that included the most commonly used comprehensive measure of depressive and anxiety disorder symptoms and diagnoses, in primary care depression RCTs (the Revised Clinical Interview Schedule: CIS-R). Two-stage random-effects meta-analyses were conducted.
RESULTS: Twelve (n = 6024) of thirteen eligible studies (n = 6175) provided individual patient data. There was a 31% (95%CI: 25 to 37) difference in depressive symptoms at 3-4 months per standard deviation increase in baseline depressive symptoms. Four additional factors: the duration of anxiety; duration of depression; comorbid panic disorder; and a history of antidepressant treatment were also independently associated with poorer prognosis. There was evidence that the difference in prognosis when these factors were combined could be of clinical importance. Adding these variables improved the amount of variance explained in 3-4 month depressive symptoms from 16% using depressive symptom severity alone to 27%. Risk of bias (assessed with QUIPS) was low in all studies and quality (assessed with GRADE) was high. Sensitivity analyses did not alter our conclusions.
CONCLUSIONS: When adults seek treatment for depression clinicians should routinely assess for the duration of anxiety, duration of depression, comorbid panic disorder, and a history of antidepressant treatment alongside depressive symptom severity. This could provide clinicians and patients with useful and desired information to elucidate prognosis and aid the clinical management of depression.
Depression, individual patient data meta-analysis, prognosis, systematic review, treatment outcome
1068-1081
Buckman, Joshua E J
72f4352d-7903-416f-82df-f69d90308129
Saunders, Rob
14f8666e-a131-4130-a7b1-a358d84d5cb2
Cohen, Zachary D
2ac2bcd9-b47b-458c-a241-cccd311c1e8a
Barnett, Phoebe
5a3eafb0-059f-4fe8-96e8-b0ae46c1b505
Clarke, Katherine
cddc1aed-8a81-4870-8806-c9621c7ab782
Ambler, Gareth
3b9b18c5-1f7b-4608-b86f-30491d1c2418
DeRubeis, Robert J
311dbb2e-7779-4c26-95fb-895a3853284c
Gilbody, Simon
6d135882-a8df-444c-85aa-980dddef45a5
Hollon, Steven D
faca54db-7076-4c3c-955e-03333b2e7a54
Kendrick, Tony
c697a72c-c698-469d-8ac2-f00df40583e5
Watkins, Edward
4474dca0-035b-4aba-b3fb-b6d7180abfb9
Wiles, Nicola
fcec2769-de78-4b86-b9c1-eab754a02837
Kessler, David
3659e526-e667-46cb-bd9c-02bce7d58d41
Richards, David
c9b253b3-641c-4163-99b8-2b5908ce18f7
Sharp, Deborah
5be021f2-ec75-4317-bf7d-f02328a50107
Brabyn, Sally
aae0a41d-5239-46e8-a5d5-a54809f7afb2
Littlewood, Elizabeth
49eaf7da-20eb-4857-b5f4-67c06ecbb199
Salisbury, Chris
50e9a5a0-c074-4af8-9b1b-e1e8408aae3c
White, Ian R
dd2d3538-6baf-4da9-8083-2447abbed4fb
Lewis, Glyn
11aed8f6-3905-455e-8e89-34147a5e5d26
Pilling, Stephen
f8b9c11e-7720-493c-8739-7813980ff3e4
14 April 2021
Buckman, Joshua E J
72f4352d-7903-416f-82df-f69d90308129
Saunders, Rob
14f8666e-a131-4130-a7b1-a358d84d5cb2
Cohen, Zachary D
2ac2bcd9-b47b-458c-a241-cccd311c1e8a
Barnett, Phoebe
5a3eafb0-059f-4fe8-96e8-b0ae46c1b505
Clarke, Katherine
cddc1aed-8a81-4870-8806-c9621c7ab782
Ambler, Gareth
3b9b18c5-1f7b-4608-b86f-30491d1c2418
DeRubeis, Robert J
311dbb2e-7779-4c26-95fb-895a3853284c
Gilbody, Simon
6d135882-a8df-444c-85aa-980dddef45a5
Hollon, Steven D
faca54db-7076-4c3c-955e-03333b2e7a54
Kendrick, Tony
c697a72c-c698-469d-8ac2-f00df40583e5
Watkins, Edward
4474dca0-035b-4aba-b3fb-b6d7180abfb9
Wiles, Nicola
fcec2769-de78-4b86-b9c1-eab754a02837
Kessler, David
3659e526-e667-46cb-bd9c-02bce7d58d41
Richards, David
c9b253b3-641c-4163-99b8-2b5908ce18f7
Sharp, Deborah
5be021f2-ec75-4317-bf7d-f02328a50107
Brabyn, Sally
aae0a41d-5239-46e8-a5d5-a54809f7afb2
Littlewood, Elizabeth
49eaf7da-20eb-4857-b5f4-67c06ecbb199
Salisbury, Chris
50e9a5a0-c074-4af8-9b1b-e1e8408aae3c
White, Ian R
dd2d3538-6baf-4da9-8083-2447abbed4fb
Lewis, Glyn
11aed8f6-3905-455e-8e89-34147a5e5d26
Pilling, Stephen
f8b9c11e-7720-493c-8739-7813980ff3e4
Buckman, Joshua E J, Saunders, Rob, Cohen, Zachary D, Barnett, Phoebe, Clarke, Katherine, Ambler, Gareth, DeRubeis, Robert J, Gilbody, Simon, Hollon, Steven D, Kendrick, Tony, Watkins, Edward, Wiles, Nicola, Kessler, David, Richards, David, Sharp, Deborah, Brabyn, Sally, Littlewood, Elizabeth, Salisbury, Chris, White, Ian R, Lewis, Glyn and Pilling, Stephen
(2021)
The contribution of depressive 'disorder characteristics' to determinations of prognosis for adults with depression: an individual patient data meta-analysis.
Psychological Medicine, 51 (7), .
(doi:10.1017/S0033291721001367).
Abstract
BACKGROUND: This study aimed to investigate general factors associated with prognosis regardless of the type of treatment received, for adults with depression in primary care.
METHODS: We searched Medline, Embase, PsycINFO and Cochrane Central (inception to 12/01/2020) for RCTs that included the most commonly used comprehensive measure of depressive and anxiety disorder symptoms and diagnoses, in primary care depression RCTs (the Revised Clinical Interview Schedule: CIS-R). Two-stage random-effects meta-analyses were conducted.
RESULTS: Twelve (n = 6024) of thirteen eligible studies (n = 6175) provided individual patient data. There was a 31% (95%CI: 25 to 37) difference in depressive symptoms at 3-4 months per standard deviation increase in baseline depressive symptoms. Four additional factors: the duration of anxiety; duration of depression; comorbid panic disorder; and a history of antidepressant treatment were also independently associated with poorer prognosis. There was evidence that the difference in prognosis when these factors were combined could be of clinical importance. Adding these variables improved the amount of variance explained in 3-4 month depressive symptoms from 16% using depressive symptom severity alone to 27%. Risk of bias (assessed with QUIPS) was low in all studies and quality (assessed with GRADE) was high. Sensitivity analyses did not alter our conclusions.
CONCLUSIONS: When adults seek treatment for depression clinicians should routinely assess for the duration of anxiety, duration of depression, comorbid panic disorder, and a history of antidepressant treatment alongside depressive symptom severity. This could provide clinicians and patients with useful and desired information to elucidate prognosis and aid the clinical management of depression.
This record has no associated files available for download.
More information
Accepted/In Press date: 2021
e-pub ahead of print date: 14 April 2021
Published date: 14 April 2021
Additional Information:
Funding Information:
3. COBALT: The National Institute for Health Research Health Technology Assessment (NIHR HTA) programme (project number 06/404/02).
Funding Information:
4. GENPOD: Medical Research Council and supported by the Mental Health Research Network.
Funding Information:
5. HEALTHLINES: NIHR under its Programme Grant for Applied Research (Grant Reference Number RP-PG-0108-10011).
Funding Information:
Financial support. This study was supported by the Wellcome Trust through a Clinical Research Fellowship to JB (201292/Z/16/Z), Medical Research Council (Programme for IW: MC_UU_12023/21), MQ Foundation (for ZC: MQDS16/72), the Higher Education Funding Council for England, the National Institute of Health Research (NIHR), NIHR University College London Hospitals Biomedical Research Centre (RS, KC, PB and SP), NIHR Biomedical Research Centre at the University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol (NW and DK), University College London (GA and GL), University of Pennsylvania (RDR), Vanderbilt University (SDH), University of Southampton (TK), University of Exeter (EW) and University of York (SG). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. The studies that make up the Dep-GP IPD database were funded by:
Publisher Copyright:
Copyright © The Author(s), 2021. Published by Cambridge University Press.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
Keywords:
Depression, individual patient data meta-analysis, prognosis, systematic review, treatment outcome
Identifiers
Local EPrints ID: 449548
URI: http://eprints.soton.ac.uk/id/eprint/449548
ISSN: 0033-2917
PURE UUID: 4d443f86-29cf-409a-89ee-f31a742474c9
Catalogue record
Date deposited: 07 Jun 2021 16:31
Last modified: 17 Mar 2024 02:47
Export record
Altmetrics
Contributors
Author:
Joshua E J Buckman
Author:
Rob Saunders
Author:
Zachary D Cohen
Author:
Phoebe Barnett
Author:
Katherine Clarke
Author:
Gareth Ambler
Author:
Robert J DeRubeis
Author:
Simon Gilbody
Author:
Steven D Hollon
Author:
Edward Watkins
Author:
Nicola Wiles
Author:
David Kessler
Author:
David Richards
Author:
Deborah Sharp
Author:
Sally Brabyn
Author:
Elizabeth Littlewood
Author:
Chris Salisbury
Author:
Ian R White
Author:
Glyn Lewis
Author:
Stephen Pilling
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics